Essex Woodlands IX, LLC
10% Owner

Essex Woodlands IX, LLC insider trades: EyePoint Pharmaceuticals (EYPT) stock buys and sales

10% Owner, EyePoint Pharmaceuticals Last trade Sep 1, 2023 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2018
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Essex Woodlands IX, LLC reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 1, 2023EYPT↓ Sell$198K
Aug 31, 2023EYPT↓ Sell$1.5M
Aug 29, 2023EYPT↓ Sell$1.7M
Aug 25, 2023EYPT↓ Sell$3.0M
Aug 23, 2023EYPT↓ Sell$2.3M
Dec 15, 2021VERO↑ Buy$4.7M
Dec 15, 2021VERO↑ Buy$190K
Jun 25, 2018EYPT↑ Buy$20.5M
Jun 25, 2018EYPT↑ Buy$825K
Mar 28, 2018PSDV↑ Buy$9.1M
Mar 28, 2018PSDV↑ Buy$366K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other EYPT insiders

Open-market trades in the last 12 months

About Essex Woodlands IX, LLC's insider trades

Essex Woodlands IX, LLC is a 10% owner of EyePoint Pharmaceuticals (EYPT). Since Mar 28, 2018, it has reported 6 open-market purchases worth $35.7M and 5 sales worth $8.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (8 filings), conversions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EYPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.